As of 2026-09-04, the Relative Valuation of Neogenomics Inc (NEO) is (12.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.46 USD, the upside of Neogenomics Inc based on Relative Valuation is -170.0%.
The range of the Relative Valuation is (12.77) - (11.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.6x - 33.3x | 32.8x |
| Forward P/E multiples | 27.3x - 28.2x | 27.8x |
| Fair Price | (12.77) - (11.39) | (12.22) |
| Upside | -173.1% - -165.3% | -170.0% |
| Date | P/E |
| 2026-09-03 | -43.24 |
| 2026-09-02 | -43.09 |
| 2026-09-01 | -43.22 |
| 2026-08-31 | -44.36 |
| 2026-08-28 | -44.70 |
| 2026-08-27 | -46.16 |
| 2026-08-26 | -43.02 |
| 2026-08-25 | -41.58 |
| 2026-08-24 | -40.64 |
| 2026-08-21 | -42.05 |
| 2026-08-20 | -40.94 |
| 2026-08-19 | -41.25 |
| 2026-08-18 | -39.38 |
| 2026-08-17 | -40.02 |
| 2026-08-14 | -39.48 |
| 2026-08-13 | -40.59 |
| 2026-08-12 | -40.67 |
| 2026-08-11 | -40.94 |
| 2026-08-10 | -41.19 |
| 2026-08-07 | -41.04 |
| 2026-08-06 | -38.54 |
| 2026-08-05 | -38.96 |
| 2026-08-04 | -40.34 |
| 2026-08-03 | -39.23 |
| 2026-07-31 | -37.87 |
| 2026-07-30 | -39.33 |
| 2026-07-29 | -37.82 |
| 2026-07-28 | -33.19 |
| 2026-07-27 | -32.54 |
| 2026-07-24 | -34.40 |
| 2026-07-23 | -35.27 |
| 2026-07-22 | -34.70 |
| 2026-07-21 | -35.79 |
| 2026-07-20 | -35.27 |
| 2026-07-17 | -36.18 |
| 2026-07-16 | -36.75 |
| 2026-07-15 | -35.91 |
| 2026-07-14 | -35.24 |
| 2026-07-13 | -34.94 |
| 2026-07-10 | -34.94 |
| 2026-07-09 | -36.48 |
| 2026-07-08 | -35.27 |
| 2026-07-07 | -35.91 |
| 2026-07-06 | -37.54 |
| 2026-07-02 | -37.54 |
| 2026-07-01 | -37.07 |
| 2026-06-30 | -36.13 |
| 2026-06-29 | -35.29 |
| 2026-06-26 | -35.09 |
| 2026-06-25 | -34.00 |